Improvement of quality of reporting in randomised controlled trials to prevent hypotension after spinal anaesthesia for caesarean section by Herdan, A. et al.
REVIEW ARTICLE
Improvement of quality of reporting in randomised
controlled trials to prevent hypotension after spinal
anaesthesia for caesarean section
A. Herdan & R. Roth & D. Grass & M. Klimek & S. Will &
B. Schauf & R. Rossaint & M. Heesen
Received: 18 November 2010 /Accepted: 3 December 2010 /Published online: 18 December 2010
# The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract Hypotension is a frequent complication of spinal
anaesthesia for caesarean section and can threaten the well-
being of the unborn child. Numerous randomised controlled
trials (RCTs) dealt with measures to prevent hypotension.
The aim of this study was to determine the reporting quality
of RCTs using the Consolidated Standards of Reporting
Trials (CONSORT) statement since low quality can lend
false credibility to a study and overestimate the effect of an
intervention. We performed a systematic literature search in
PubMed to identify relevant RCTs in a pre-CONSORT
period (1990–1994) and a post-CONSORT period (2004–
2008). A comparative evaluation was done between the two
periods, and the trials were assessed for compliance with
each of the 22 CONSORT items. A total of 37 RCTs was
identified. The CONSORT score increased significantly
(p<0.05) from 66.7% (±12.5%) in the pre-CONSORT
period to 87.4% (±6.9%) in the post-CONSORT period. A
statistically significant improvement was found for eight
items, including randomization, blinding and intention-to-
treat analysis. The CONSORT score in the post-CONSORT
era was fairly good, also in comparison to other medical
fields. In the post-CONSORT era, reporting of important
items improved, in particular in the domains that are crucial
to avoid bias and to improve internal validity. Use of
CONSORT should be encouraged in order to keep or even
improve the reporting quality.
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Background
Hypotension is considered a major side effect of spinal
anaesthesia for caesarean section that can compromise
foetal circulation, causing hypoxia and foetal acidosis in
the unborn baby [1]. Many randomised controlled trials
(RCTs), the gold standard of clinical research, were
undertaken to study measures aiming to prevent hypoten-
sion. In a previous report, we demonstrated that research in
this field is limited by a wide variety of definitions of
hypotension making it difficult if not impossible to
compare the results of the RCTs [2].
The present study sought to evaluate the quality of RCTs
in this field. Incomplete data reporting and methodological
flaws can limit the value of a RCT. In order to avoid that
poor studies receive false credibility, readers need to
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evaluate the quality of the methods. In response to growing
concerns about the quality of clinical trials, a group of 30
experts including medical journal editors, clinical trialists,
epidemiologists and methodologists identified 22 items for
which there was evidence that inadequate reporting can
introduce bias. A checklist containing all 22 items and a
flow diagram were designed, both instruments examining
transparent reporting of chronological enrolment, interven-
tion allocation, follow-up and data analysis. So the
Consolidated Standards of Reporting Trials (CONSORT)
statement was developed and first published in 1996; a
revised version was issued in 2001 [3].
There is evidence that studies with a low-quality
reporting tend to overestimate the effect of the evaluated
intervention by 30–50% [4]. For the assessment of quality
of reporting of clinical studies, the CONSORT tool offers
some advantages. Proper performance of randomisation,
blinding of randomisation and blinding of the subjects and
investigators to study interventions will help to reduce bias
in clinical studies [5]. Eligibility criteria relate to the
external validity of the study, assisting the clinician to
decide whether the results of the trial can be applied to his
own patients. Scientific validity is reflected by aspects
involving statistical analysis. In addition, standards for
abstract and title facilitate the process of finding relevant
articles.
Since quality of reporting RCTs of interventions to
prevent hypotension due to spinal anaesthesia in parturients
undergoing caesarean section has not been systematically
assessed the present study applied the CONSORT checklist
to RCTs. We compared a period before CONSORT (1990–
1994) with a post-CONSORT period (2004–2008).
Methods
To identify relevant literature, we performed a PubMed
with the search terms “caesarean section” and “hypoten-
sion” and “randomised controlled trial” as well as a hand-
search of anaesthesiologic journals, the journals Obstetrics
and Gynecology as well as the American Journal of
Obstetrics and Gynecology. The search was restricted to
articles in English language. Two periods were searched: A
first period comprised the time from January 1, 1990 until
December 31, 1994. The second period ranged from
January 1, 2004 until December 31, 2008.
The retrieved articles were then independently screened for
eligibility by two authors. Studies were included into this
review when healthy parturients scheduled for caesarean
section under spinal anaesthesia were randomly assigned to at
least one intervention arm that aimed to prevent or treat
anaesthesia-induced hypotension. In agreement with others
[6], blinding of the graders was not performed since research
on the impact of blinding on the evaluation of quality of
RCTs has yielded ambiguous results [7, 8].
The CONSORT statement was used to evaluate the
reporting quality of the included trials. Each of the 22
CONSORT items was graded as either “yes” or “no”. In
case that blinding was not possible, a “not applicable” was
also possible. The CONSORT score of each RCT was
calculated by adding the correctly reported domains of the
CONSORT checklist and expressed as percentage of the
maximally available number (in general out of 22, out of 21
in cases that blinding was not possible). All domains had
the same weight.
For the purpose of this study, the reviewers underwent
systematic training. Initially, they received the German
version of the “Revised CONSORT statement for reporting
randomised trials: Explanation and elaboration document”
which provides the meaning of each item and examples of
good practise. Consecutively, they were trained by scoring
two articles that were not part of this review.
All reports were independently graded by two inves-
tigators. According to our protocol, a third reviewer had to
be involved if consensus was not reached between the two
first investigators.
To assess chance-adjusted interrater reliability, Cohen’s
kappa statistic was determined. This method involves the
degree of reviewers’ agreement on whether a domain was
reported or not. It was calculated for three articles that were
not included into this study.
The articles were grouped by publication period (1990–
1994: pre-CONSORT; 2004–2008: post-CONSORT). The
pre- and post-CONSORT periods were compared by calcu-
lating the odds ratio and the 95% confidence interval for each
domain. CONSORT scores are given as mean ± standard
deviation. Student’s t test served for the comparison of
CONSORT scores in the two periods. The level of statistical
significance was set at the two-sided 0.05 value.
Findings
We identified 48 articles with our search strategy of which
37 [9–45] met the inclusion criteria (Fig. 1). All articles
found by the hand-search were also retrieved by the
PubMed search. Of these 37 articles, 13 were published in
the pre-CONSORT period (1990–1994) and 24 in the post-
CONSORT period (2004–2008). Table 1 shows the sources
of the retrieved articles, 33 articles were published in
anaesthesiologic journals, two in obstetric journals and two
others in general medical journals.
The CONSORT scores increased from 66.7±12.5% in the
pre-CONSORT period to 87.4 ±6.9% in the post-CONSORT
era (p<0.01). Agreement between the evaluators was good
with a k=0.94 (0.92–0.96).
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Figure 2 portrays the percentage of correctly described
CONSORT items in the pre- and post-CONSORT era. More
than a third of all articles from both periods reported
90–100% correctly, and only 5% had a correct reporting of
40–50% of the CONSORT items. When comparing the two
time periods, a significant improvement was observed in
eight items including sample size calculation, method of
randomization, implementation of randomization, blinding,
statistical methods, participant flow, intention-to-treat analysis
(ITT) and generalizability. A non-significant improvement
was found for endpoints, allocation concealment, baseline
data, outcomes and estimation of effect, ancillary analysis,
interpretation of results and overall evidence (Table 2). For
two items, a decrease of correctly reporting articles was
found, i.e. recruitment and follow-up as well as adverse
effects. In the pre-CONSORT period, five domains were
correctly reported in all 13 articles.
Discussion
To our knowledge, this is the first study evaluating the
compliance with CONSORT of RCTs dealing with hypoten-
sion due to spinal anaesthesia for caesarean section. Our
approach of studying a period before publication of CONSORT
with a time period thereafter has several precedents [6, 46, 47].
As a major result, we found a significant increase in the
CONSORT scores from 66.7% to 87.4%. Also, a statisti-
cally significant improvement was observed for eight items
after CONSORT was published and an improvement in
seven items that did not reach statistical significance. Of the
total of 22 items, five items were already correctly reported
in the pre-CONSORT era.
A remarkable improvement in the items relating to
randomization was found. This is critical for the detection
of selection bias, and deficiencies were associated with an
exaggeration of the treatment effect [4, 48]. Another area of
improvement was the participant flow diagram which is
intended to explicitly report the number of subjects
undergoing randomization, receiving treatment, the number
of dropouts and the number finally being analysed [49].
ITT was used by all reports of the post-CONSORT era
versus ten out of 13 pre-CONSORT articles. ITT is strongly
recommended since it preserves the randomization process
and allows for non-compliance and deviations from policy
Assessed articles: 48 
  11 articles excluded: 
    1 descriptive study 
    1 retrospective study 
    1 cohort study 
    8 non-RCT  prospec- 
    tive studies  
RCTs identified: 37 
Fig. 1 Flow diagram with included and excluded articles
Table 1 Source of articles
Journal Number of articles
Anaesthesia journals
Anaesthesia 5
Anesthesia & Analgesia 6
Anesthesiology 4
British Journal of Anaesthesia 5
Canadian Journal of Anesthesia 3
International Journal of Obstetric Anesthesia 6
Anaesthesia and Intensive Care 2
Acta Anaesthesiologica Scandinavica 1
Journal of Clinical Anesthesiology 1
Other journals
American Journal of Obstetrics
and Gynecology
1
Obstetrics and Gynecology 1
Journal of Clinical Monitoring and Computing 1
Journal of International Medical Research 1
Total 37
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Fig. 2 Percentage of correct CONSORT items in individual articles in
the pre- (1990–1994) and post-CONSORT (2004–2008) period
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[50]. ITT together with methods of randomization and
blinding is crucial for internal validity and helps to avoid
selection, performance, detection and attrition bias [5].
Sample size calculation was an item that showed the
sharpest increase over time, i.e. the percentage of trails
correctly reporting on this item increased from 23% (three
of 13 reports) to 71% (17 of 24 reports) in the post-
CONSORT period. Sample size calculation is required to
quantitatively estimate the power of a trial to answer the
studied question [46]. Underpowered trials are prone to bias
and can negatively affect the quality of meta-analyses [46].
However, it has to be emphasized that this CONSORT item
only evaluates whether a sample size calculation has been
performed but it does not give information of whether this
calculation is correct or not.
Interestingly, our analysis found a lower percentage of
correct reporting for the items recruitment and follow-up as
well as adverse effects in the post- versus the pre-
CONSORT period, although statistically not significant. It
could be speculated that the reporting of adverse effects
was omitted since authors feared that the occurrence of side
effects and complications could question their positive
results and lead to a rejection of the manuscript. The fact
that inadequate reporting is found in the more recent papers
could be due to the increasing competition in the academic
field leading to a growing pressure to produce publications,
since the number of authored papers is one of the
parameters for evaluating scientific careers [51, 52]. A
report that evaluated surgical papers which were published
in 2005 confirmed our finding of a high rate of inadequate
reporting of adverse effects [53]. Editors should probably
draw the conclusion that authors have to be encouraged to
report on undesired effects. Proper definition and reporting
of adverse events is crucial for critical appraisal of study
results and, in addition, facilitates systematic reviews and
meta-analysis. Previous studies showed that acute surveil-
lance, i.e. actively asking study subjects whether undesired
events occurred by use of structured questionnaires, inter-
Table 2 Proportion of reporting of CONSORT items in randomised controlled trials in periods pre- (1990–1994) and post-CONSORT (2004–2008)
Data items Combined Pre-CONSORT Post-CONSORT Odds ratio (95% CI) p value
Title and abstract
Randomised 1.0 (37) 1.0 (13) 1.0 (24) 1.0
Introduction
Scientific background 1.0 (37) 1.0 (13) 1.0 (24) 1.0
Eligibility criteria for participants 1.0 (37) 1.0 (13) 1.0 (24) 1.0
Details of Intervention 1.0 (37) 1.0 (13) 1.0 (24) 1.0
Objectives 1.0 (37) 1.0 (13) 1.0 (24) 1.0
Endpoints 0.89 (33) 0.77 (10) 0.96 (23) 6.9 (0.69; 74.51) 0.115
Sample size 0.54 (20) 0.23 (3) 0.71 (17) 8.1 (1.70; 38.58) 0.007
Methods of randomization 0.70 (26) 0.38 (5) 0.88 (21) 11.2 (2.11; 58.37) 0.003
Allocation concealment 0.57 (21) 0.38 (5) 0.67 (16) 3.2 (1.17; 8.74) 0.096
Implementation of randomization 0.41 (15) 0.08 (1) 0.58 (14) 16.8 (1.87; 150.73) 0.003
Blinding 0.65 (24) 0.31(4) 0.8 (20) 11.25 (2.29; 55.35) 0.0023
Statistical methods 0.89 (33) 0.69 (9) 1.0 (24) 0.011
Results
Participant flow 0.91 (34) 0.77 (10) 1.0 (24) 0.037
Recruitment + follow-up 0.51 (19) 0.61 (8) 0.46 (11) 0.53 (0.13; 2.10) 0.895
Baseline data 0.95 (35) 0.85 (11) 1.0 (24) 0.12
Intention-to-treat analysis 0.92 (34) 0.76 (10) 1.0 (24) 0.037
Outcome and estimation 0.95 (35) 0.85 (11) 1.0 (24) 0.12
Ancillary analysis 0.29 (11) 0.15 (2) 0.38 (9) 3.3 (0.59; 18.40) 0.15
Adverse effects 0.81 (30) 0.92 (12) 0.75 (18) 0.25 (0.03; 2.34) 0.9
Discussion
Interpretation of results 0.95 (35) 0.84 (11) 1.0 (24) 0.12
Generalizability 0.86 (32) 0.69 (9) 0.96 (23) 10.22 (1.00; 104.0) 0.042
Overall evidence 0.95 (35) 0.85 (11) 1.0 (24) 0.12
CI confidence interval
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views or diagnostic tests at predefined time intervals, is
more effective than passive disclosure [44, 45]. Reporting
of adverse events should already be considered during
study design since data on adverse events are less
susceptible to bias and confounders when they are collected
prospectively rather than retrospectively [54, 55]. Our
finding is confirmed by a study about the reporting quality
of surgical trials [53]
There are many other tools to evaluate the quality of RCTs.
We chose the CONSORTchecklist for several reasons. Firstly,
CONSORT is officially supported by the World Association
of Medical Authors and the International Committee of
Medical Journal Editors. Secondly, several reports demon-
strated that poor compliance with CONSORT criteria is
associated with an exaggeration of the effect size. Moher
and colleagues found that RCTs that were not double-blind
overestimated the effects by 17% [4]. Inadequate or unclear
allocation concealment exaggerated odds ratios by 41% and
30%, respectively. A similar finding was obtained by another
group [56]. An exaggeration of the treatment effect in single
RCTs by inappropriate reporting has also consequences for
subsequent meta-analyses, considered to be the highest level
of evidence-based medicine and often guiding our clinical
practise. In their meta-analysis on anticoagulants, Lensing et
al. [57] clearly favoured low molecular heparins. However,
when taking quality of reporting of the underlying RCTs into
consideration, superiority of low molecular weight heparin
on mortality due to venous thrombosis was no longer given
[4]. Exclusion of low-quality trials may thus directly impact
our clinical practise.
It is probably a consequence of its widespread use that
CONSORT has already been proven effective: A meta-
analysis including 248 articles clearly demonstrated an
improvement of the reporting of RCTs by the adoption of
this tool [49]. It is noteworthy that these authors compared
a time period before CONSORT publication with a period
thereafter; this approach was also chosen in our report.
Thirdly, CONSORT has in the meantime been applied in
many other medical specialities [53, 58]. We used the
CONSORT checklist in its 2001 version. An update has
been published very recently [59], after our study was
completed. However, use of the 2001 version allows us to
compare our results with those obtained in other medical
specialities and therapeutic areas.
In only 12% of trials of analgesics given for pain relief
after trauma or orthopaedic surgery sample size calculation
was reported [60]. This percentage was 54% in our survey,
combining the pre- and post-CONSORT period. The reason
for the discrepancy could be due to the fact that the other
group included trials published from 1966 on, thus covering
a time period when probably little or no attention was paid
to this issue, whereas our early period began much later, in
1990. In a study of nutritional support trials [58], use of
blinding was found to increase significantly from 19% to
41% from a pre- (before 1996) to the post-CONSORT (after
1996) era. We observed an increase from 31% to 80%. In
our study, intention-to-treat analysis was used in 76% of the
pre-CONSORT and in 100% of the post-CONSORT
articles, an improvement reaching statistical significance.
No improvement was found for this parameter in the study
by Doig and colleagues [58].
The CONSORT score of urological and non-urological
surgical trials published between 2000 and 2003 was 11.1
and 11.2 (corresponding to 50.45% and 50.90%) [61],
respectively, which is much lower than the CONSORT
scores in either of our study periods.
Comparing our results with a study of obstetric anaes-
thesia trials could be of particular interest. This report by
Halpern and colleagues [61] focussed on articles published
from June 2000 to June 2002, providing no information on
whether reporting quality might have changed over time.
When comparing the reports included into this study [61],
which were published between June 2000 and June 2002,
with articles from our post-CONSORT era (2004–2009), we
found a higher percentage of correctly reported CONSORT
items in our study. More than 80% correctly reported
domains were observed in 62% of our articles whereas less
than 5% of the articles from the study by Halpern et al. [61]
reach this value. The majority of the obstetric anaesthesia
articles only ranged between 50% and 70% correctly
reported items, compared to less than 5% in our sample
of RCTs of interventions to prevent hypotension after spinal
anaesthesia. We think it is the time difference between the
two studies (2004 to 2009) in our post-CONSORT period
versus June 2000 to June 2002 in the study by Halpern et
al. [61] which accounts for the higher percentage of
compliance with some CONSORT items in our study, since
awareness of the CONSORT statement published in 1996
(respective in 2001 for the revised version) had less time to
spread in the study period of Halpern et al. [61]. This
notion receives further support from studies by others: Only
few improvements could be observed when comparing
trials from before 1996 with those appearing immediately
after 1996 [60]. Moher et al. [46] also considered it a flaw
of their study that their post-CONSORT period began only
12 to 18 months after publication of CONSORT. They
argued that “effective dissemination is a slow process and
that to estimate the true influence of CONSORT requires
more time.”
It is a limitation of our study that we do not provide data
on the association of quality of reporting and CONSORT
adoption. We did not test for the association between the
CONSORT score in adopters and non- or late adopters
since every additional analysis increases the likelihood of a
type I error, i.e. incorrectly inferring that there is a
significant differences when there is no such difference.
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In summary, the CONSORT scores increased over time
from 66.7% to 87.4%, reflecting a remarkable improve-
ment. We observed a significantly better reporting in eight
of 22 items in the post-CONSORT compared to the pre-
CONSORT period. However, we saw a decrease, although
statistically not significant, in the reporting of adverse
events which deserves further attention.
Conclusion
We conclude from our study that the reporting quality has
improved significantly in the period after dissemination of
the CONSORT statement. Therefore, journal editors,
reviewers and authors should be encouraged to adhere to
the CONSORT checklist in order to ensure high-quality
trials. Consequently, clinicians can spend more time
considering the findings, rather than scrutinizing quality
of reporting of the trial.
Declaration of interest The authors report no conflicts of interest.
The authors alone are responsible for the content and writing of the
paper.
Open Access This article is distributed under the terms of the Creative
Commons Attribution Noncommercial License which permits any
noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.
References
1. Corke BC, Datta S, Ostheimer GW, Weiss JB, Alper MH (1982)
Spinal anaesthesia for caesarean section. The influence of
hypotension on neonatal outcome. Anaesthesia 37:658–662
2. Klöhr S, Roth R, Hofmann T, Rossaint R, Heesen M (2010)
Definitions of hypotension after spinal anaesthesia for caesarean
section: systematic literature search and application to parturients.
Acta Anaesthiol Scand 1:1–13
3. Moher D, Schulz KF, Altman DG (2001) The CONSORT
statement: revised recommendations for improving the quality of
reports of parallel-group randomised trials. Lancet 357:1191–1194
4. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M,
Tugwell P, Klassen TP (1998) Does quality of reports of
randomised trials affect estimates of intervention efficacy reported
in meta-analyses? Lancet 352:609–613
5. Jüni P, Altman DG, Egger M (2001) Systematic reviews in health
care: assessing the quality of controlled clinical trials. BMJ 323:42–46
6. Moher D, Jones A, Lepage L, CONSORT group (2001) Use of the
CONSORT statement and quality of reports of randomized trials: a
comparative before- and after-evaluation. JAMA 285:1992–1995
7. Berlin JA (1997) Does blinding of readers affect the results of
meta-analysis? University of Pennsylvania Meta-Analysis Blinding
Study Group. Lancet 350:185–186
8. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynold DJ,
Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports
of randomized clinical trials: is blinding necessary? Control Clin
Trials 17:1–12
9. Bhagwanjee S, Rocke DA, Rout CC, Koovarjee RV, Brijball R
(1990) Prevention of hypotension following spinal anaesthesia for
elective caesarean section by wrapping of the legs. Br J Anaesth
70:819–822
10. Moran DH, Perillo M, La Porta RF, Bader AM, Datta S (1991)
Phenylephrine in the prevention of hypotension following spinal
anesthesia for cesarean delivery. J Cin Anesth 3:301–305
11. Wright PMC, Iftikhar M, Fitzpatrick KT, Moore J, Thompson W
(1992) Vasopressor therapy for hypotension during epidural
anesthesia for cesarean section: effects on maternal and fetal flow
velocity ratios. Anesth Analg 75:56–63
12. Rout CC, Rocke DA, Brijball R, Koovarjee RV (1992) Prophylactic
intramuscular ephedrine prior to caesarean section. Anaesth Intensive
Care 20:448–452
13. Rout CC, Akoojee SS, Rocke DA, Gouws E (1992) Rapid
administration of crystalloid preload does not decrease the
incidence of hypotension after spinal anaesthesia for elective
caesarean section. Br J Anaesth 68:394–397
14. Rout CC, Rocke DA, Levin J, Gouws E, Reddy D (1993) A
reevaluation of the role of crystalloid preload in the prevention of
hypotension associated with spinal anaesthesia for elective
caesarean section. Anesthesiology 79:262–269
15. Rout CC, RockeDA,Gouws E (1993) Leg elevation and wrapping in
the prevention of hypotension following spinal anaesthesia for
elective caesarean section. Anaesthesia 48:304–308
16. Kafle SK (1993) Intrathecal meperidine for elective caesarean
section: a comparison with lidocaine. Can J Anaesth 40:718–
721
17. Campbell DC, Douglas MJ, Pavy TJG, Merrick P, Flanagan ML,
McMorland GH (1993) Comparison of the 25-gauge Whitacre
with the 24-gauge Sprotte spinal needle for elective caesarean
section: cost implications. Can J Anaesth 40:1131–1135
18. Thoren T, Holmström B, Rawal N, Schollin J, Lindeberg S,
Skeppner G (1994) Sequential combined spinal epidural block
versus spinal block for caesarean section: effects on maternal
hypotension and neurobehavioral function of the newborn. Anesth
Analg 78:1087–1092
19. Ramin SM, Ramin KD, Cox K, Magness RR, Shearer VE, Gant
NF (1994) Comparison of prophylactic angiotensin II versus
ephedrine infusion for prevention of maternal hypotension during
spinal anesthesia. Am J Obstet Gynecol 171:734–739
20. Hall PA, Bennett A, Wilkes MP, Lewis M (1994) Spinal
anaesthesia for caesarean section: comparison of infusion of
phenylephrine and ephedrine. Br J Anaesth 73:471–474
21. Filos KS, Goudas LC, Patroni O, Polyzou V (1994) Hemodynamic
and analgesic profile after intrathecal clonidine in humans. Anesthe-
siology 81:591–601
22. Loughrey JPR, Yao S, Datta S, Segal S, Pian-Smith M, Tsen LC
(2005) Hemodynamic effects of spinal anesthesia and simultaneous
intravenous bolus of combined phenylephrine and ephedrine versus
ephedrine for cesarean delivery. Int J Obstet Anesth 14:43–47
23. Harten JM, Boyne I, Hannah P, Varveris D, Brown A (2005)
Effects of a height and weight adjusted dose of local anesthetic for
spinal anesthesia for elective caesarean section. Anaesthesia
60:348–352
24. Hallworth SP, Fernando R, Columb MO, Stocks GM (2005) The
effect of posture and baricity on the spread of intrathecal
bupivacaine for elective cesarean delivery. Anesth Analg
100:1159–1165
25. Kee WDN, Khaw KS, Ng FF (2005) Prevention of hypotension
during spinal anesthesia for cesarean delivery. Anesthesiology
103:744–750
26. Dahlgren G, Granath F, Pregner K, Rösblad PG, Wessel H, Irested
L (2005) Colloid vs. crystalloid preloading to prevent maternal
hypotension during spinal anesthesia for elective cesarean section.
Acta Anaesthesiol Scand 49:1200–1206
126 Gynecol Surg (2011) 8:121–127
27. Desalu I, Kushimo OT (2005) Is ephedrine infusion more
effective at preventing hypotension than traditional prehydration
during spinal anaesthesia for caesarean section in African
parturients? Int J Obstet Anesth 14:294–299
28. Davies P, French GWG (2006) A randomized trial comparing
5 ml/kg and 10 ml/kg of pentastarch as a volume preload before
spinal anaesthesia for elective caesarean section. Int J Obstet
Anesth 15:279–283
29. Hanss R, Bein B, Francksen H, Scherkl W, Bauer M, Doerges V,
Steinfath M, Scholz J, Tonner PH (2006) Heart rate variability-
guided prophylactic treatment of severe hypotension after sub-
arachnoid block for elective caesarean delivery. Anesthesiology
104:635–643
30. Van de VeldeM, Van Schoubroeck D, Jani J, Teunkens A,Missant C,
Deprest J (2006) Combined spinal–epidural anesthesia for cesarean
delivery: dose dependent effects of hyperbaric bupivacaine on
maternal hemodynamics. Anesth Analg 103:187–190
31. Parpaglioni R, Frigo MG, Lemma A, Sebastiani M, Barbati G,
Celleno D (2006) Minimum local anaesthetic dose (MLAD) of
intrathecal levobupivacaine and ropivacaine for caesarean section.
Anaesthesia 61:110–115
32. Coppejans HC, Hendrickx E, Goossens J, Vercauteren MP (2006)
The sitting versus right lateral position during combined spinal–
epidural anesthesia for cesarean delivery: block characteristics and
severity of hypotension. Anesth Analg 102:243–247
33. Saravanan S, Kocarev M, Wilson RC, Watkins E, Columb MO,
Lyons G (2006) Equivalent dose of ephedrine and phenylephrine
in the prevention of post-spinal hypotension in caesarean section.
Br J Anaesth 96:95–99
34. Ko JS, Kim CS, Cho HS, Choi DH (2007) A randomized trial of
crystalloid versus colloid solution for prevention of hypotension
during spinal or low-dose combined spinal–epidural anesthesia for
elective cesarean delivery. Int J Obstet Anesth 16:8–12
35. Dahlgren G, Granath F, Wessel H, Irestedt L (2007) Prediction of
hypotension during spinal anesthesia for caesarean section and its
relation to the effect of crystalloid or colloid preload. Int J Obstet
Anesth 16:128–134
36. Nishikawa K, Yokoyama N, Saito S, Goto F (2007) Comparison
of the effects of rapid colloid loading before and after spinal
anesthesia on maternal hemodynamics and neonatal outcomes in
caesarean section. J Clin Monit Comput 21:125–129
37. Kundra P, Khanna S, Habeebullah S, Ravishankar M (2007)
Manual displacement of the uterus during caesarean section.
Anaesthesia 62:460–465
38. Bryson GL, MacNeil R, Jeyaraj LM, Rosaeg OP (2007) Small
dose spinal bupivacaine for caesarean delivery does not reduce
hypotension but accelerates motor recovery. Can J Anaesth
54:531–537
39. Siddiqui M, Goldszmidt E, Fallah S, Kingdom J, Windrim R,
Carvalho JCA (2007) Complications of exteriorized compared
with in situ uterine repair at cesarean delivery under spinal
anesthesia. Obstet Gynecol 110:570–575
40. Kaya S, Karaman H, Erdogan H, Akyilmaz A, Turhanoglu S
(2007) Combined use of low-dose bupivacaine, colloid preload
and wrapping of the legs for preventing hypotension in spinal
anaesthesia for Caesaren section. JIMR 35:615–625
41. Arai YPC, Kato N, Matsura M, Ito H, Kandatsu N, Kurokawa S,
Mizutani M, Shibata Y, Komatsu T (2008) Transcutaneous
electrical nerve stimulation at the PC-5 and PC-6 acupoints
reduced the severity of hypotension after spinal anaesthesia in
patients undergoing caesarean section. Br J Anaesth 100:78–81
42. Cesur M, Alici HA, Erdem AF, Borekci B, Silbir F (2008)
Spinal anesthesia with sequential administration of plain and
hyperbaric bupivacaine provides satisfactory analgesia with
hemodynamic stability in caesarean section. Int J Obstet
Anesth 17:217–222
43. Ngan Kee WD, Lee A, Khaw KS, Ng FF, Karmakar MK, Gin T
(2008) A randomized double-blinded comparison of phenyleph-
rine and ephedrine infusion combinations to maintain blood
pressure during spinal anesthesia for cesarean delivery: the effects
on fetal acid–base status and hemodynamic control. Anesth Analg
107:1295–1302
44. Ngan Kee WD, Khaw KS, Lau TK, Ng FF, Chui K, Ng KL
(2008) Randomized double-blinded comparison of phenylephrine
vs ephedrine for maintaining blood pressure during spinal
anaesthesia for non-elective caesarean section. Anaesthesia
63:1319–1326
45. Zhou ZQ, Shao Q, Zeng Q, Song J, Yang JJ (2008) Lumbar
wedge versus pelvic wedge in preventing hypotension following
combined spinal epidural anaesthesia for caesarean delivery.
Anaesth Intensive Care 36:835–839
46. Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C,
Gaboury I (2006) Does the CONSORT checklist improve the
quality of reports of randomized controlled trails? A systematic
review. Med J Aust 185:263–267
47. Lee KP, Schotland M, Bacchetti P, Bero LA (2002) Association of
journal quality indicators with methodological quality of clinical
research articles. JAMA 287:2805–2808
48. Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical
evidence of bias. Dimensions of methodological quality associated
with estimates of treatment effects in controlled trials. JAMA
273:408–412
49. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne
D, Gotzsche PC, Lang T, CONSORT Group (2001) The revised
CONSORT statement for reporting randomised trials: explanation
and elaboration. Ann Intern Med 134:663–694
50. Hollis S, Campbell F (1999) What is meant by intention to treat
analysis? Survey of published randomised trials. BMJ 319:670–674
51. Pile K (2009) Publish or perish. Int J Rheum Dis 12:183–185
52. Anderson MS, Ronning EA, De Vries R, Martinson BC (2007)
The perverse effects of competition on scientists’ work and
relationships. Sci Eng Ethics 13:437–461
53. Sinha S, Sinha S, Ashby E, Jayaram R, Grocott MPW (2009)
Quality of reporting in randomized trials published in high-quality
surgical journals. J Am Coll Surg 209:565–571
54. Ioannidis JP, Evans SJ, Gotzsche PC, O’Neill RT, Altman DG,
Schulz K, Moher D, CONSORT Group (2004) Better reporting of
harms in randomised trials: an extension of the CONSORT
statement. Ann Intern Med 141:781–788
55. Nagurney JT, Brown DF, Sane S, Weiner JB, Wang AC, Chang Y
(2005) The accuracy and completeness of data collected by
prospective and retrospective methods. Acad EmergMed 12:884–895
56. Hewitt C, Hahn S, Torgenson DJ, Watson J, Bland JM (2005)
Adequacy and reporting of allocation concealment: review of
recent trials published in four general medical journals. BMJ
330:1057–1058
57. Lensing AW, Prins MH, Davidson BL, Hirsh J (1995) Treatment
of deep venous thrombosis with low-molecular-weight heparins.
A meta-analysis. Arch Intern Med 155:601–607
58. Doig GS, Simpson F, Delaney A (2005) A review of the true
methodological of nutritional support trials conducted in the
critically ill: time for improvement. Anesth Analg 100:527–533
59. Schulz KF, Altman DG, Moher D, CONSORT Group (2010)
CONSORT 2010 statement: updated guidelines for reporting
parallel group randomized trials. Ann Intern Med 152:726–732
60. Montaigne VA, Vidal X, Aguilera C, Lahore JR (2010) Reporting
randomised clinical trials of analgesics after traumatic or
orthopaedic surgery is inadequate: a systematic review. BMC
Clin Pharmacol 10:1–6
61. Halpern SH, Darani R, Douglas MJ, Wight W, Yee J (2004)
Compliance with the CONSORT checklist in obstetric anaesthesia
controlled trials. Int J Obstet Anesth 13:207–214
Gynecol Surg (2011) 8:121–127 127
